Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Avalo Therapeutics (AVTX) Inventory Average (2018 - 2023)

Avalo Therapeutics filings provide 6 years of Inventory Average readings, the most recent being $18500.0 for Q2 2023.

  • On a quarterly basis, Inventory Average fell 22.92% to $18500.0 in Q2 2023 year-over-year; TTM through Jun 2023 was $18500.0, a 22.92% decrease, with the full-year FY2022 number at $29000.0, up 41.46% from a year prior.
  • Inventory Average hit $18500.0 in Q2 2023 for Avalo Therapeutics, down from $19500.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $682452.5 in Q1 2019 to a low of $6030.0 in Q4 2020.
  • Median Inventory Average over the past 5 years was $20250.0 (2022), compared with a mean of $80425.1.
  • Biggest five-year swings in Inventory Average: tumbled 97.24% in 2020 and later skyrocketed 347.76% in 2021.
  • Avalo Therapeutics' Inventory Average stood at $211800.5 in 2019, then plummeted by 97.15% to $6030.0 in 2020, then skyrocketed by 347.76% to $27000.0 in 2021, then dropped by 22.22% to $21000.0 in 2022, then decreased by 11.9% to $18500.0 in 2023.
  • The last three reported values for Inventory Average were $18500.0 (Q2 2023), $19500.0 (Q1 2023), and $21000.0 (Q4 2022) per Business Quant data.